Search by Drug Name or NDC
NDC 11673-0430-15 Eye Allergy Relief .2675; 3.15 mg/mL; mg/mL Details
Eye Allergy Relief .2675; 3.15 mg/mL; mg/mL
Eye Allergy Relief is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN OTC DRUG category. It is labeled and distributed by Target Corporation. The primary component is NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE.
Product Information
| NDC | 11673-0430 |
|---|---|
| Product ID | 11673-430_27951c6f-9048-45ed-b304-768afaad35a1 |
| Associated GPIs | 86409902142015 |
| GCN Sequence Number | 051262 |
| GCN Sequence Number Description | naphazoline HCl/pheniramine DROPS .0268-.315 OPHTHALMIC |
| HIC3 | Q2H |
| HIC3 Description | EYE ANTIHISTAMINE-VASOCONSTRICTOR COMBINATIONS |
| GCN | 18447 |
| HICL Sequence Number | 003407 |
| HICL Sequence Number Description | NAPHAZOLINE HCL/PHENIRAMINE MALEATE |
| Brand/Generic | Generic |
| Proprietary Name | Eye Allergy Relief |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Pheniramine Maleate and Naphazoline Hydrochloride |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Active Ingredient Strength | .2675; 3.15 |
| Active Ingredient Units | mg/mL; mg/mL |
| Substance Name | NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE |
| Labeler Name | Target Corporation |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020065 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 11673-0430-15 (11673043015)
| NDC Package Code | 11673-430-15 |
|---|---|
| Billing NDC | 11673043015 |
| Package | 1 BOTTLE, DROPPER in 1 CARTON (11673-430-15) / 15 mL in 1 BOTTLE, DROPPER |
| Marketing Start Date | 2010-08-31 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |